Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Omega-6 fats in certain cells boost male hormone production.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Testosterone is vital for male health, and its deficiency is linked to aging and common health issues.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

The document aimed to understand how certain treatments affect blood vessel growth in rat prostates.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

A new compound was made that might help treat diseases related to male hormones.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.